Implementing a Simple Pharmacovigilance Program to Improve Reporting of Adverse Events Associated with Biologic Therapy in Rheumatology: Preliminary Results from the Calabria Biologics Pharmacovigilance Program (CBPP)Caterina Palleria,Luigi Iannone,Christian Leporini,Rita Citraro,Antonia Manti,Maurizio Caminiti,Pietro Gigliotti,Rosa Daniela Grembiale,Massimo L'Andolina, Giuseppe Muccari,Maria Diana Naturale,Domenico Olivo,Giuseppa Pagano Mariano,Roberta Pellegrini,Giuseppe Varcasia,Karim Abdalla,Emilio Russo,Francesco Ursini,Giovambattista De SarroPloS one(2018)引用 9|浏览45暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要